Conference
CA15-3/MUC1 in CCTG MA-32 (NCT01101438): A phase III RCT of the effect of metformin vs. placebo on invasive disease free and overall survival in early stage breast cancer (BC).
Authors
Dowling RJ; Parulekar WR; Gelmon KA; Shepherd LE; Virk S; Ennis M; Mao F; Ligibel JA; Hershman DL; Rastogi P
Volume
36
Pagination
pp. 557-557
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
May 20, 2018
DOI
10.1200/jco.2018.36.15_suppl.557
Conference proceedings
Journal of Clinical Oncology
Issue
15_suppl
ISSN
0732-183X